Screening Asia 2013

Venue: Biopolis Shared Facilities

Location: Singapore, Singapore

Event Date/Time: Nov 12, 2013 End Date/Time: Nov 13, 2013
Report as Spam


Screening Asia will focus on advances in discovery technologies, such as 3D cell-based assays and label free screening, as well as the use of model organisms such as C. elegans. Natural product screening and emerging targets will also be discussed.

Running alongside the Screening Asia 2013 conference will be an exhibition covering the latest technological advances and associated services within this field. Registered delegates will also have access to the co-located Lab-on-a-Chip Asia and Genomics Research Asia conference tracks, ensuring a cost effective trip.


Agenda Topics:

  • Advances in Enabling Discovery Technologies
    • 3D Cell-based Assays
    • Biologics
    • High Content Assays
    • High Content Flow Cytometry
    • Label Free Screening Technologies
    • Model Organisms e.g. C. elegans
    • Patient Derived iPSC Cells
    • Screening Stem Cells
    • Target ID and Validation
  • Natural Product Diversity & Novel Chemistries to Fill in the RnD Pipeline
  • Addressing Emerging & Challenging Targets
  • Assessing Natural Product Toxicities
  • Bioassay Based Fractionation
  • Natural Product Screening
  • Novel Chemical Library Designs
  • Repurposing Existing Approved Drugs
  • Synthetic Biology for Complex Chemistries


30 Biopolis Street

Conference Speakers

Keynote Speakers:


Vicky Avery Professor, Griffith University

Barry O'Keefe Section Head, Protein Chemistry and Molecular Biology , National Institutes of Health